8/1/2007

8/1/2007

8/1/2007

8/1/2007

8/1/2007

8/1/2007

Researchers conducted a review of 46 previously published studies on cardiovascular disease (CVD) involving omega-3 fatty acid consumption. After careful review of the collective data, researchers concluded that increased omega-3 consumption from fish or fish oil supplements, but not alpha linolenic acid (ALA) from foods such as flax, reduces the risk of all-cause mortality, cardiac and sudden death, and possibly stroke.

Although significant benefits were observed in both, the primary-prevention (prevention of a first-time cardiovascular event such as heart attack or stroke) and secondary-prevention (prevention of a second or greater cardiovascular event) groups, the evidence for secondary prevention is much stronger. There was no high-quality data to support a benefit of ALA consumption for CVD risk reduction.

"n-3 Fatty acids from fish oil fish-oil supplements, but not a-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review." Am. J. Clin. Nutr. 2006; 84:5-17.


8/1/2007

Disclaimer: The statements and information upon this website have not necessarily been evaluated by the Food and Drug Administration. The products featured are not intended to diagnose, treat, cure or prevent any disease. Consumers should always consult their own medical practitioner(s) with any medical or health concerns before starting any new diet, product or supplement.